Alexion Pharmaceuticals Inc. (ALXN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

121 SEAPORT BOULEVARD BOSTON, MA 02210

Alexion Pharmaceuticals Inc. discovers and develops therapeutic products to treat patients with disease states including hematologic, cardiovascular and autoimmune disorders and cancer. Its lead product candidates are therapeutic antibodies that address diseases that arise when the human immune system produces inflammation.

Data based on most recent fiscal year report
Market Cap24.012 Billion Shares Outstanding223.41 Million Avg Volume3.552 Million
1-Yr BETA vs S&P TR Current Ratio3.1 Quick Ratio2.62
View SEC Filings from ALXN instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ALXN now:
Filers who had this stock in their top 10: 11 3 (0.31%)
13F Filers holding this stock: 610 71 (7.33%)
Aggregate 13F shares on 06/30/2019: 208.455 Million 20.329 Million
Aggregate 13F shares on 03/31/2019: 211.911 Million 19.884 Million
Percent change: -1.63% 2.23%
Funds creating new positions: 84 18
Funds Adding to an existing position: 247 28
Funds closing out their position: 55 7
Funds reducing their position: 193 15
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALXN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAKER BROS. ADVISORS LP

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2019-10-10 1

WRIGHT FRANK J

  • Director
10,356 2019-09-30 0

ANDERSON DAVID J

  • Director
0 2019-09-30 0

CLANCY PAUL J

  • Director
2,226 2019-09-30 4

HALLAL DAVID

  • Director
290,595 2019-09-18 0

SQUINTO STEPHEN P

  • Director
  • 10% Owner
7,406,307 2019-09-17 0

ISLAM SAQIB CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
971,552 2019-09-12 0

WAGNER HEIDI L

  • Director
0 2019-09-04 0

FRIEDMAN PAUL A

  • Director
315,531 2019-08-02 1

COUGHLIN CHRISTOPHER J

  • Director
4,183 2019-07-30 1

MATHIS LARRY

  • Director
60,450 2019-07-09 0

FRANCHINI INDRANI LALL EVP, CHIEF COMPLIANCE OFFICER

  • Officer
29,627 2019-07-01 6

NADER FRANCOIS

  • Director
23,747 2019-06-24 1

SARIN ARADHANA CHIEF STRATEGY & BUSINESS OFF

  • Officer
30,201 2019-06-21 4

DUNSIRE DEBORAH

  • Director
7,875 2019-06-11 1

MONNET DOMINIQUE

  • Director
0 2019-06-10 0

LAW ANNE-MARIE EVP, CHIEF EXPERIENCE OFFICER

  • Officer
35,092 2019-06-07 3

ORLOFF JOHN J EVP, RESEARCH & DEVELOPMENT

  • Officer
37,791 2019-06-07 3

GOFF BRIAN EVP & CHIEF COMMERCIAL OFFICER

  • Officer
41,776 2019-06-07 4

BURNS M MICHELE

  • Director
16,516 2019-06-04 0

MACKAY MARTIN

  • Director
7,827 2019-05-22 0

RUMMELT ANDREAS

  • Director
22,146 2019-05-15 1

MOLLEN JOHN T

  • Director
9,233 2019-05-15 1

BRENNAN DAVID R

  • Director
55,221 2019-05-15 1

REINSDORF JUDITH A

  • Director
7,452 2019-05-15 1

O'NEILL JULIE

  • Director
0 2019-04-17 0

HANTSON LUDWIG

  • Director
2,795 2019-03-07 4

MORIARTY JOHN B EVP, GENERAL COUNSEL

  • Officer
39,952 2019-03-04 0

CHINIARA ELLEN EVP & GENERAL COUNSEL

  • Officer
7,711 2019-02-28 2

BAZARKO DANIEL SVP, CONTROLLER, CAO

  • Officer
4,140 2019-02-28 6

THIEL CARSTEN

  • Director
0 2018-08-31 0

NORBY R DOUGLAS

  • Director
0 2018-05-31 0

VENEMAN ANN M

  • Director
5,480 2017-09-05 0

PARVEN ALVIN S

  • Director
7,568 2017-06-15 0

BELL LEONARD

  • Director
390,670 2017-02-28 0

CARMICHAEL CLARE EVP, CHIEF HR OFFICER

  • Officer
39,161 2017-02-27 0

MILLER EDWARD SVP, CHIEF COMPLIANCE OFFICER

  • Officer
19,284 2017-02-27 0

SINHA VIKAS EVP & CFO

  • Officer
178,463 2016-08-08 0

KELLER WILLIAM R

  • Director
7,276 2014-12-04 0

LINK MAX

  • Director
77,069 2014-08-12 0

MADRI JOSEPH A

  • Director
179,217 2014-03-11 0

COISSAC PATRICE SVP & PRES. ALXN PHARMA INT'L

  • Officer
1,118 2012-10-31 0

DUBIN THOMAS I H SVP & CHIEF LEGAL OFFICER

  • Officer
65,705 2012-08-23 0

WAEGER RUEDI E

  • Director
No longer subject to file 2011-06-01 0

KEISER DAVID W

  • Director
149,546 2009-06-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments